(Q36863422)

16 August 2017

1 reference

title

Antiepileptic medication during pregnancy: does fetal genotype affect outcome? (English)

1 reference

16 August 2017

Diane E Atkinson

1

1 reference

16 August 2017

Sophie Brice-Bennett

series ordinal

2

1 reference

16 August 2017

Stephen W D'Souza

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

62

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

120-127

1 reference

https://scigraph.springernature.com/pub.10.1203/pdr.0b013e3180a02e50

16 August 2017

exact match

0 references

cites work

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

In utero antiepileptic drug exposure: fetal death and malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

MDR1 P-gp expression and activity in intact human placental tissue; upregulation by retroviral transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

The longer term outcome of children born to mothers with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Pregnancy in the woman with epilepsy: maternal and fetal outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Antiepileptic drug use of women with epilepsy and congenital malformations in offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Maternal valproate dosage and foetal malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Lamotrigine and the risk of malformations in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Experimental studies on reproductive toxicologic effects of lamotrigine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Cardioskeletal mitochondria1 myopathy associated with chronic magnesium deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

The teratogenicity of anticonvulsant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Additional educational needs in children born to mothers with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Normal intelligence in children with prenatal exposure to carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Children exposed to valproate in utero--population based evaluation of risks and confounding factors for long-term neurocognitive development

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Role of multidrug transporters in pharmacoresistance to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Potential role of drug transporters in the pathogenesis of medically intractable epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

MDR1 gene expression in brain of patients with medically intractable epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Significance of MDR1 and multiple drug resistance in refractory human epileptic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Kinetic analysis of P-glycoprotein-mediated transport by using normal human placental brush-border membrane vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Functional role of P-glycoprotein in the human blood-placental barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

A multidrug resistance transporter from human MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Genetic polymorphisms of the human MDR1 drug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Functional and structural consequences of cysteine substitutions in the NH2 proximal region of the human multidrug resistance protein 1 (MRP1/ABCC1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Increased rate of major malformations in offspring exposed to valproate during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Major malformations in offspring of women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Epilepsy and pregnancy: lamotrigine as main drug used

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3180A02E50

Common antiepileptic drugs in pregnancy in women with epilepsy

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD004848

Identifiers

DOI

10.1203/PDR.0B013E3180A02E50

1 reference

Dimensions Publication ID

16 August 2017

1010112888

0 references

1 reference